摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Ag(2,3'-DCPA)(CF3SO3)]2 | 196080-61-2

中文名称
——
中文别名
——
英文名称
[Ag(2,3'-DCPA)(CF3SO3)]2
英文别名
2,3'-dicyanodiphenylacetylene silver(I) triflate;disilver;2-[2-(3-cyanophenyl)ethynyl]benzonitrile;trifluoromethanesulfonate
[Ag(2,3'-DCPA)(CF3SO3)]2化学式
CAS
196080-61-2
化学式
C34H16Ag2F6N4O6S2
mdl
——
分子量
970.383
InChiKey
DNZOQRXLFXGHMV-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.76
  • 重原子数:
    54
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    226
  • 氢给体数:
    0
  • 氢受体数:
    16

反应信息

  • 作为产物:
    参考文献:
    名称:
    Association of Dicyanodiphenylacetylenes with Silver(I) Salts in Solution and Solid State:  Electrospray Ionization Mass Spectrometry Samples Aggregates at Subsaturated Concentrations
    摘要:
    Complexes of 2,3'-dicyanodiphenylacetylene (2,3'-DCPA, 1), 2,2'-dicyanodiphenylacetylene (2,2'-DCPA, 2), and 2,4'-dicyanodiphenylacetylene (2,4'-DCPA, 3) with silver(I) salts have been characterized in the solid state by single-crystal X-ray analysis. In addition, aggregates of compounds 1-3 and silver(I) ions have been identified in solution by electrospray ionization mass spectrometry (ESI-MS). The topology of the structures in the solid state, namely finite versus infinite, is found to depend on the substitution pattern of nitrile groups on diphenylacetylene. For 2,3'-DCPA. (1), crystallization with silver(I) triflate (AgCF3SO3), silver(I) perchlorate hydrate (AgClO4 . xH(2)O, x similar to 1), or silver(I) hexafluoroantimonate (AgSbF6) produces cyclic dimers of composition [Ag(1)(X)](2) (X = CF3SO3-(4) or ClO4- (5)) and {[Ag(1)](SbF6)}(2) (6). For these structures, 2,3'-DCPA coordinates to silver(I) ions in a cisoid conformation with respect to the orientation of nitrile groups. Significant deformations of the cyclic dimers are observed as a function of the counterion employed. In contrast to the finite structures involving 2,3'-DCPA, crystallization of 2,2'-DCPA (2) with AgCF3SO3 yields the infinite chain structure [Ag(2)(CF3SO3)] (7). 2,2'-DCPA coordinates to silver(I) in a transoid conformation resulting in a ''half-bow-tie'' motif for the chains. Crystallization of 2,4'-DCPA (3) with AgCF3SO3 produces the infinite, undulating sheet structure [Ag(3)(CF3SO3)] (8) in which helical chains of 2,4'-DCPA coordinated to silver(I) ions are bridged by triflate counterions. Positive ion ESI-MS of solutions of 2,3'-DCPA (1) and AgCF3SO3, AgClO4 . H2O, or AgSbF6 in acetone or acetonitrile show a distribution of aggregates including [Ag-2(1)(2)(X)](+) (X = CF3SO3-, ClO4-, or SbF6-). The composition of these species corresponds to that of the cyclic dimers of complexes 4-6 minus one counterion, X. With 2,2'-DCPA (2) and AgCF3SO3 in acetone or acetonitrile, the aggregates [Ag(2)](+) and [Ag(2)(2)](+) are observed and higher adducts are noted to be present in much lower abundance. It is believed that the predominance of adducts involving one silver(I) ion is due to the formation of chelated species in solution in which 2,2'-DCPA coordinates to a silver(I) ion in a cisoid conformation. Molecular modeling suggests that such species are viable. ESI-MS of 2,4'-DCPA (3) and AgCF3SO3 in acetone or acetonitrile shows the existence of [Ag(3)](+) as well as higher aggregates which are less prevalent. For a given Ligand, aggregation at concentrations of the Ligand and silver(I) salt of ca. 10(-3) M is significant in acetone, however, it is largely disrupted in acetonitrile due to the predominance of acetonitrile Ag(I) adducts. Analysis of the ESI-MS data for all three ligands with AgCF3SO3 in acetone or acetonitrile shows that the aggregate [Ag-2(L)(2)(CF3SO3)](+) is most abundant for L = 2,3'-DCPA (1). It is postulated that the relatively high abundance of [Ag-2(1)(2)(CF3SO3)](+) is indicative of the formation of a cyclic dimer in solution that resembles complex 4.Similarly, it is believed that cyclic dimers exist in solution with ClO4- and SbF6- as well.
    DOI:
    10.1021/ja971135g
点击查看最新优质反应信息

同类化合物

([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) (R)-斯替戊喷酯-d9 (E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E)-3-(4-(叔丁基)苯基)丙烯酸乙酯 (E)-3-(2-(三氟甲基)苯基)丙烯酸乙酯 (E)-3-(2,4-二甲氧基苯基)丙烯酸乙酯 (E/Z)-他莫昔芬-d5 (5Z)-7-氧杂烯醇 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S,5R,5''R)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4R,5S)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (4-甲氧基-6-[(E)-2-(3-甲氧基苯基)乙烯基]-5,6-二氢-2H-吡 (2Z)-1,3-二苯基-2-丙烯-1-酮,2-丙烯-1-酮,1,3-二苯基-,(2Z)- (2E)-N-[2-(3-羟基-2-氧代-2,3-二氢-1H-吲哚-3-基)乙基]-3-苯基丙-2-烯酰胺 (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 (11aR)-3,7-双(3,5-二甲基苯基)-10,11,12,13-四氢-5-羟基-5-氧化物-二茚基[7,1-de:1'',7''-fg][1,3,2]二氧杂膦酸 龙血素D 龙血素C 龙血素A 龙血素 B 龙血树脂红血树脂 鼠李素 鼠李柠檬素3-O-beta-D-鼠李三糖苷 鼠李柠檬素 鼠李亭3-O-beta-吡喃葡萄糖苷 鼓槌石斛素 黄麦格霉素 黄金树苷 黄酮醇-2-磺酸钠盐 黄酮胺 黄酮榕碱 黄酮地洛 黄酮哌酯 黄酮 黄豆黄苷 黄豆黄素 黄豆苷元-D6 黄豆苷元-4,7-二葡糖苷 黄诺马甙 黄苏木素 黄花夹竹桃黄酮 黄芪总皂甙 黄芪异黄烷苷,7,2'-二羟基-3',4'-二甲氧基异黄烷 黄芩黄酮II 黄芩黄酮I 黄芩黄酮 黄芩苷甲酯 黄芩苷 黄芩素磷酸酯